Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8e8c5137ae75c2bdeee5509a0b7207b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-10034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-08 |
filingDate |
2002-01-22^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8db52861ff66d115679c052fd0dbd3e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fe2d56050f8110125b64d96b781bb64 |
publicationDate |
2002-08-15^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-02062368-A2 |
titleOfInvention |
Method of inducing a ctl response |
abstract |
Disclosed herein are methods for inducing an immunological CTL response to an antigen by sustained, regular delivery of the antigen to a mammal so that the antigen reaches the lymphatic system. Antigen is delivered at a level sufficient to induce an immunologic CTL response in a mammal and the level of the antigen in the mammal's lymphatic system is maintained over time sufficient to maintain the immunologic CTL response. Also disclosed is an article of manufacture for delivering an antigen that induces a CTL response in an animal. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006071990-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703142-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114965-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014227323-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470330-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7850971-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007682-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007682-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695248-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006071990-A2 |
priorityDate |
2001-02-02^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |